Clinical Trials Browser

Phase 2 × Suspended × Head and Neck Neoplasms × Clear all

NCT05420948 2026-04-09

A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Phase 2 Suspended

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms